ClinicalTrials.gg
CompletedNCT07863518Updated Oct 7, 2026

Transcranial Direct Current Stimulation Combined With Tai Chi for Dual-Task Mobility and Cognitive Function in Older Adults With Cognitive Decline

An interventional study of Tai Chi and Transcranial Direct Current Stimulation in Mild Cognitive Impairment (MCI) and Self-Reported Memory Concerns, sponsored by Shanghai University of Sport. Completed at 2 sites in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Shanghai University of Sport · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Dec 2024, registered Sep 2026).
Updated Oct 7, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This randomized clinical trial evaluated the effects of transcranial direct current stimulation (tDCS) combined with Tai Chi on dual-task mobility, cognitive function, and physical function in older adults with mild cognitive impairment or self-reported memory concerns. Participants were randomly assigned to receive either Tai Chi combined with tDCS or Tai Chi alone for 8 weeks. Assessments were conducted at baseline and at Weeks 8, 20, and 32. Outcome measures included dual-task Timed Up and Go (DT-TUG) time, single-task TUG, dual-task cost, Montreal Cognitive Assessment-Basic (MoCA-B), Digit Span Test, balance, gait, lower-extremity function, health-related quality of life, sleep quality, anxiety, and depressive symptoms.

02

Conditions studied

  • Mild Cognitive Impairment (MCI)
  • Self-Reported Memory Concerns
03

In context

Cognitive Dysfunction

3,932 studies on the registry are indexed under Cognitive Dysfunction; 1,114 are open to participants now.

This study's enrollment of 61 is close to the median of 64 across 2,855 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Shanghai University of Sport is the lead sponsor of 21 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 65 years or older.
  • Self-reported memory decline or memory concern.
  • Clinical Dementia Rating (CDR) global score of 0.5 or lower.
  • No major difficulties in performing activities of daily living.
  • Ability to participate safely in supervised moderate-intensity physical activity.
  • Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of dementia or a Montreal Cognitive Assessment-Basic (MoCA-B) score below the prespecified education-specific cutoff suggestive of dementia (\<13 for participants with 6 or fewer years of education, \<15 for those with 7-12 years, and \<16 for those with more than 12 years of education).
  • Neurologic disease, such as Parkinson disease or stroke, musculoskeletal disorders, or other conditions precluding safe participation in Tai Chi training.
  • Contraindications to transcranial direct current stimulation (tDCS), such as intracranial metal implants.
  • Regular participation in moderate-intensity exercise or Tai Chi (>3 sessions per week for >20 minutes per session) within the preceding 3 months.
  • Participation in a structured cognitive intervention or pharmacologic clinical trial within the preceding year.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    Combined Intervention

    Participants received an 8-week supervised Tai Chi program combined with 20 sessions of left dorsolateral prefrontal cortex-targeted transcranial direct current stimulation (tDCS). Each tDCS session lasted 20 minutes and was administered immediately before Tai Chi practice.

    Behavioral: Tai Chi · Device: Transcranial Direct Current Stimulation

  • Active comparator
    Tai Chi Only

    Participants received the same 8-week supervised Tai Chi program without tDCS.

    Behavioral: Tai Chi

Interventions

  • BehavioralTai Chi

    An 8-week supervised Tai Chi program consisting of 40 planned sessions (5 sessions per week, 40 minutes per session). Each session included a 5-minute warm-up, 30 minutes of Tai Chi practice, and a 5-minute cool-down. The curriculum was adapted from a tailored Tai Ji Quan protocol based on the standardized 24-form Yang-style sequence and included eight forms practiced on both sides when applicable.

  • DeviceTranscranial Direct Current Stimulation

    Model-guided transcranial direct current stimulation targeting the left dorsolateral prefrontal cortex was delivered using a Starstim system (Neuroelectrics, Barcelona, Spain) with a four-electrode Ag/AgCl gel montage. Twenty stimulation sessions were planned over 8 weeks. Each session lasted 20 minutes and was administered immediately before Tai Chi practice. The montage consisted of an anodal electrode at F3 (+1500 μA) and cathodal return electrodes at AF4 (-545 μA), FC5 (-523 μA), and FC1 (-432 μA). The current delivered through any single electrode did not exceed 1.5 mA, and the total injected current remained below 4 mA. Each session included 59-second ramp-up and ramp-down periods.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Dual-Task Timed Up and Go (DT-TUG) Time

    Dual-task mobility was assessed using the Timed Up and Go test performed while simultaneously completing serial subtraction by 3 from a three-digit number. DT-TUG time was recorded in seconds and averaged across three trials. Shorter times indicate better dual-task mobility. Changes from baseline were assessed at Weeks 8, 20, and 32.

    Time frame: Baseline to Weeks 8, 20, and 32

Secondary outcomes

  1. Change From Baseline in Montreal Cognitive Assessment-Basic (MoCA-B) Total Score

    Global cognitive function was assessed using the Chinese version of the Montreal Cognitive Assessment-Basic (MoCA-B). Total scores range from 0 to 30, with higher scores indicating better global cognitive function. Change from baseline in MoCA-B total score was evaluated at each post-intervention assessment.

    Time frame: Baseline to Weeks 8, 20, and 32

  2. Change From Baseline in Dual-Task Cost to Timed Up and Go Time

    Dual-task cost (DTC) to TUG time was calculated as \[(dual-task TUG time - single-task TUG time) / single-task TUG time\] × 100 and expressed as a percentage. Lower values indicate a smaller performance cost associated with performing the cognitive task during mobility.

    Time frame: Baseline to Weeks 8, 20, and 32

  3. Change From Baseline in Digit Span Test-Forward Score

    Attention and short-term memory were assessed using the Digit Span Test-Forward. Higher scores indicate better performance.

    Time frame: Baseline to Weeks 8, 20, and 32

  4. Change From Baseline in Digit Span Test-Backward Score

    Working memory was assessed using the Digit Span Test-Backward. Higher scores indicate better performance.

    Time frame: Baseline to Weeks 8, 20, and 32

Other outcomes

  1. Change From Baseline in Single-Task Timed Up and Go (ST-TUG) Time

    Single-task functional mobility was assessed using the Timed Up and Go test. Participants stood from a chair, walked 3 m, turned, walked back, and sat down at their usual safe pace. TUG time was recorded in seconds and averaged across three trials. Shorter times indicate better mobility.

    Time frame: Baseline to Weeks 8, 20, and 32

  2. Change From Baseline in Sit-to-Stand Duration During DT-TUG

    The sit-to-stand phase of the DT-TUG was identified from video recordings using predefined movement-event criteria. Phase duration was measured in seconds and averaged across three trials. Shorter durations indicate faster performance of the sit-to-stand phase.

    Time frame: Baseline to Weeks 8, 20, and 32

  3. Change From Baseline in Straight-Walking Duration During DT-TUG

    Straight-walking duration during the DT-TUG was derived from video recordings and defined as the sum of the outbound and return walking times. Phase duration was measured in seconds and averaged across three trials. Shorter durations indicate faster straight-walking performance.

    Time frame: Baseline to Weeks 8, 20, and 32

  4. Change From Baseline in Turning Duration During DT-TUG

    Turning duration during the DT-TUG was derived from video recordings and defined as the duration of the 180° turn around the midpoint marker. Phase duration was measured in seconds and averaged across three trials. Shorter durations indicate faster turning performance.

    Time frame: Baseline to Weeks 8, 20, and 32

  5. Change From Baseline in Turn-to-Sit Duration During DT-TUG

    Turn-to-sit duration during the DT-TUG was derived from video recordings and defined as the interval from initiation of the final chair-facing turn to completion of sitting. Phase duration was measured in seconds and averaged across three trials. Shorter durations indicate faster turn-to-sit performance.

    Time frame: Baseline to Weeks 8, 20, and 32

  6. Change From Baseline in 30-Second Chair Stand Test (30CST) Performance

    Lower-extremity functional strength was assessed using the 30-Second Chair Stand Test. Participants were instructed to complete as many full sit-to-stand repetitions as possible within 30 seconds. The total number of completed repetitions was recorded, with higher values indicating better lower-extremity functional performance.

    Time frame: Baseline to Weeks 8, 20, and 32

  7. Change From Baseline in Berg Balance Scale (BBS) Score

    Functional balance was assessed using the Berg Balance Scale (BBS), which consists of 14 functional balance tasks. Total scores range from 0 to 56, with higher scores indicating better balance function.

    Time frame: Baseline to Weeks 8, 20, and 32

  8. Change From Baseline in Functional Reach Test (FRT) Distance

    Dynamic balance was assessed using the Functional Reach Test. Participants were instructed to reach forward as far as possible while maintaining a fixed base of support. The maximal forward reach distance was recorded, with greater distances indicating better functional balance.

    Time frame: Baseline to Weeks 8, 20, and 32

  9. Change From Baseline in Pittsburgh Sleep Quality Index (PSQI) Global Score

    Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). The global score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline to Weeks 8, 20, and 32

  10. Change From Baseline in Geriatric Anxiety Inventory (GAI-20) Score

    Anxiety symptoms were assessed using the 20-item Geriatric Anxiety Inventory (GAI-20). Higher total scores indicate greater severity of anxiety symptoms.

    Time frame: Baseline to Weeks 8, 20, and 32

  11. Change From Baseline in 30-Item Geriatric Depression Scale (GDS-30) Score

    Depressive symptoms were assessed using the 30-item Geriatric Depression Scale (GDS-30). Higher total scores indicate greater severity of depressive symptoms.

    Time frame: Baseline to Weeks 8, 20, and 32

07

Study locations

2 sites
  • Maogang Town Elderly Care Service Center
    Shanghai, Shanghai Municipality, China
  • Xinqiao Town Elderly Care Service Center
    Shanghai, Shanghai Municipality, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2024 to primary completion in Feb 2025, 2 months.

Of 1,439 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 51. This study's 2 months is below that.

Counting every sponsor, half of 1,512 studies reached it within 26 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 7, 2026
StartActual
Dec 1, 2024
Primary completionActual
Feb 28, 2025
CompletionActual
Aug 15, 2025
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07863518
Lead sponsor
Shanghai University of Sport
Responsible party
Jiaojiao Lü, PhD (Associate Professor, Shanghai University of Sport) — Principal investigator
First posted
Oct 7, 2026
Start date
Dec 1, 2024
Primary completion
Feb 28, 2025
Completion
Aug 15, 2025
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion